COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,354 Articles (22,803 medRxiv, 8,551 bioRxiv)

Most recent first Previous |  Page 1229: Articles 12281-12290  | Next

Intravenous Immunoglobulin (IVIG) in Treating Non-ventilated COVID-19 Patients with Moderate to Severe Hypoxia is Pharmacoeconomically Favorable When Appropriately Targeted
Poremba, M., Dehner, M., Perreiter, A., Semma, A., Mills, K., Sakoulas, G.
10.1101/2021.09.26.21264152 — Posted: 2021-09-27
Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic
Nakornchai, T., Conci, E., Hensiek, A., Brown, J. W. L.
10.1101/2021.09.26.21264141 — Posted: 2021-09-27
Household Density and Influences from Family and Friends Shape Vaccine Intent Among Latino Families in the San Francisco Bay Area
Wojcicki, J., Escobar, M., De Castro Mendez, A., Martinez, S.
10.1101/2021.09.25.21264120 — Posted: 2021-09-27
Racial and ethnic inequalities in COVID-19 mortality within carceral settings: An analysis of Texas prisons and jails
Marquez, N., Moreno, D., Klonsky, A., Dolovich, S.
10.1101/2021.09.26.21264145 — Posted: 2021-09-27
Contact surveys reveal heterogeneities in age-group contributions to SARS-CoV-2 dynamics in the United States
Chin, T., Feehan, D. M., Buckee, C. O., Mahmud, A. S.
10.1101/2021.09.25.21264082 — Posted: 2021-09-27
pIVW: A novel Mendelian Randomization Method Accounting for Weak Instruments and Horizontal Pleiotropy with Applications to the COVID-19 Outcomes
Xu, S., Fung, W. K., Liu, Z.
10.1101/2021.09.25.21264115 — Posted: 2021-09-27
Descriptive characteristics of continuous oximetry measurement in moderate to severe COVID-19 patients
Sobel, J. A., Levy, J., Almog, R., Reiner Benaim, A., Miller, A., Eytan, D., Behar, J. A.
10.1101/2021.09.26.21264135 — Posted: 2021-09-27 Discussion: Onsite
Lower probability and shorter duration of infections after Covid-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
Ronchini, C., Gandini, S., Pasqualato, S., Mazzarella, L., Facciotti, F., Mapelli, M., IEO Covid Team, , Frige', G., Passerini, R., Pase, L., Capizzi, S., Mastrilli, F., Orecchia, R., Natoli, G., Pelicci, P. G.
10.1101/2021.09.24.21263978 — Posted: 2021-09-27
COVID-19 attack ratio among children critically depends on the time to removal and activity levels
Wu, J., Bragazzi, N. L., Scarabel, F., McCarthy, Z., David, J., LIAM/ADERSIM COVID-19 Reopening and Recovery Modeling Group
10.1101/2021.09.25.21263542 — Posted: 2021-09-27
Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections
Kennedy, A. E., Cook, L., Breznik, J. A., Cowbrough, B., Wallace, J. G., Huynh, A., Smith, J. W., Son, K., Stacey, H., Ang, J., McGeer, A., Coleman, B. L., Larche, M., Larche, M., Hambly, N., Nair, P., Ask, K., Miller, M. S., Bramson, J., Levings, M. K., Nazy, I., Svenningsen, S., Mukherjee, M., Bowdish, D. M.
10.1101/2021.09.25.21264117 — Posted: 2021-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).